A study has found that blood biomarkers for Alzheimer's disease can be measured through remote capillary sampling, which correlates with cognition in older adults. This method, involving a fingerprick blood test, may potentially be used to screen for dementia risk at home. The test appears to show promise for detecting key biomarkers of Alzheimer's disease pathology, although its application and accuracy are still being explored.